SciELO - Scientific Electronic Library Online

 
vol.3 número1Sistema de información en tecnología de asistencia para Bogotá D. C. índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Ciencias de la Salud

versión impresa ISSN 1692-7273versión On-line ISSN 2145-4507

Resumen

CARVAJAL C., Marco A.; RINCON F., Ismael  y  MONTES R., Félix. Cost-Effective Comparison Between Two Anesthesia Techniques: Sevofluorane-Remifentanyl vs Isofluorane-Remifentanyl. Rev. Cienc. Salud [online]. 2005, vol.3, n.1, pp.09-16. ISSN 1692-7273.

We are in the of costs optimization era, reason why it is necessary to make pharmaceutical economics studies to identify the costeffectiveness of today's anesthetics. Methods: this prospective study, blinded to the patient, compared the direct costs, recovery times and satisfaction of 45 patients randomly assigned to two balanced anesthesia groups (sevofluoraneremifentanil group n = 24 or isofluoraneremifentanil group n = 21) submitted to otorhinolaringology surgical procedures. Results: the times of early recovery (ocular opening, answer to commandos, extubación, orientation and room leave) were smaller in ISO group and had statistically significant difference. Variable data was found in acquisition costs of halogenados gastados, lesser for isofluorane, which also made the anesthetic supplies less expensive during surgical procedures; nevertheless, costs in the delivery room, in recovery and ambulatory room, and the total costs did not show significant differences. Satisfaction was similar between both groups. Conclusions: a sevofluorane-remifentanil based technique is not more cost-effective than to use isofluoraneremifentanil for ambulartory patients submitted to otorhinolaringology surgical procedures.

Palabras clave : Pharmaceutical economics; costbenefit analysis; anesthesia; costs.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons